Gene: LPAR1
Official Full Name: lysophosphatidic acid receptor 1provided by HGNC
Gene Summary: The integral membrane protein encoded by this gene is a lysophosphatidic acid (LPA) receptor from a group known as EDG receptors. These receptors are members of the G protein-coupled receptor superfamily. Utilized by LPA for cell signaling, EDG receptors mediate diverse biologic functions, including proliferation, platelet aggregation, smooth muscle contraction, inhibition of neuroblastoma cell differentiation, chemotaxis, and tumor cell invasion. Many transcript variants encoding a few different isoforms have been identified for this gene. [provided by RefSeq, Oct 2020]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10237 | LPAR1 Knockout cell line (HCT 116) | Human | LPAR1 | 1:2~1:4 | Negative | Online Inquiry |
KO10238 | LPAR1 Knockout cell line (HEK293) | Human | LPAR1 | 1:3~1:6 | Negative | Online Inquiry |
KO10239 | LPAR1 Knockout cell line (A549) | Human | LPAR1 | 1:3~1:4 | Negative | Online Inquiry |
LPAR1 Gene Knockout Cell Lines are sophisticated biological tools generated to facilitate the study of the lysophosphatidic acid receptor 1 (LPAR1) in various cellular contexts. These engineered cell lines have been meticulously developed through CRISPR/Cas9 gene-editing technology, which allows for precise disruption of the LPAR1 gene, resulting in a knockout phenotype. By effectively eliminating the expression of this receptor, researchers can explore the downstream signaling pathways and physiological processes influenced by LPAR1, particularly its role in tumor growth, inflammation, and cellular differentiation.
The primary function of LPAR1 involves mediating several biological responses through its activation by lysophosphatidic acid (LPA), a bioactive lipid molecule. When LPAR1 is active, it initiates a cascade of intracellular signaling events that result in cellular responses such as proliferation, migration, and survival. The knockout cell lines offer a unique platform for elucidating these processes in vitro, allowing researchers to investigate the receptor's specific contributions to various pathologies. In clinical settings, understanding LPAR1 signaling dynamics can inform therapeutic strategies that target this receptor for conditions like cancer and fibrotic diseases.
Compared to traditional knockout models or non-specific silencing methods, LPAR1 Gene Knockout Cell Lines provide unparalleled specificity and reliability, ensuring that the observed phenotypic changes are indeed due to the loss of LPAR1 function. These cell lines enable high-throughput screening and functional assays, proving invaluable for drug discovery and furthering our knowledge of receptor-mediated mechanisms.
For researchers, clinicians, and pharmaceutical developers, utilizing LPAR1 Gene Knockout Cell Lines opens doors to innovative research opportunities, driving the advancement of therapeutic interventions. The precision and reproducibility of these cell lines underscore their significance in both basic and translational research.
Our company specializes in the production of high-quality biological research tools, backed by years of expertise in genetic engineering and cellular biology. We are committed to empowering the scientific community with cutting-edge resources like LPAR1 Gene Knockout Cell Lines, which are pivotal for deciphering the complexities of disease biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.